Literature DB >> 3141692

An erroneous apolipoprotein E-3 band in high density lipoprotein fractions.

A V Rawlings1, T Deegan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3141692     DOI: 10.1007/bf01804217

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


× No keyword cloud information.
  7 in total

1.  Gel isoelectric focusing method for specific diagnosis of familial hyperlipoproteinemia type 3.

Authors:  G R Warnick; C Mayfield; J J Albers; W R Hazzard
Journal:  Clin Chem       Date:  1979-02       Impact factor: 8.327

2.  Human very low density lipoprotein apolipoprotein E isoprotein polymorphism is explained by genetic variation and posttranslational modification.

Authors:  V I Zannis; J L Breslow
Journal:  Biochemistry       Date:  1981-02-17       Impact factor: 3.162

3.  Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms.

Authors:  K H Weisgraber; S C Rall; R W Mahley
Journal:  J Biol Chem       Date:  1981-09-10       Impact factor: 5.157

4.  Proposed nomenclature of apoE isoproteins, apoE genotypes, and phenotypes.

Authors:  V I Zannis; J L Breslow; G Utermann; R W Mahley; K H Weisgraber; R J Havel; J L Goldstein; M S Brown; G Schonfeld; W R Hazzard; C Blum
Journal:  J Lipid Res       Date:  1982-08       Impact factor: 5.922

5.  Distribution of apolipoprotein E isoforms between very low and high density lipoproteins of normal subjects and hyperlipidemic patients with special reference to type III hyperlipidemia.

Authors:  L Holmquist
Journal:  Acta Med Scand       Date:  1984

6.  Apolipoprotein A-I isoforms in human lymph: effect of fat absorption.

Authors:  G Ghiselli; E J Schaefer; J A Light; H B Brewer
Journal:  J Lipid Res       Date:  1983-06       Impact factor: 5.922

7.  NIH conference. Type III hyperlipoproteinemia: diagnosis, molecular defects, pathology, and treatment.

Authors:  H B Brewer; L A Zech; R E Gregg; D Schwartz; E J Schaefer
Journal:  Ann Intern Med       Date:  1983-05       Impact factor: 25.391

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.